IP Library Granted Patent US 8,362,309
Granted Patent B2
US 8,362,309 · App. 13/385,059 · Granted Jan 29, 2013

Fragrance and methods for production of 5-epi-β-vetivone, 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one, and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-one

Inventors: Bryan N. Julien (Lexington, KY); David M. Wallace (San Diego, CA)
Assignee: Allylix, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,362,309
App. No.
13/385,059
Granted
Jan 29, 2013
Kind
B2
Abstract

The present invention is directed to novel methods for production of 5-epi-β-vetivone, 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one and 2-isopropyl-6,10-dimethylspiro[4.5]deca-1,6-dien-8-one, which are useful for their fragrant qualities. Provided are methods for production of premnaspirodiene from a terpene substrate, methods for production of 5-epi-β-vetivone from premnaspirodiene as starting material, and methods for production of 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-2,6-dien-8-one and 2-isopropyl-6,10-dimethyl-spiro[4.5]deca-1,6-dien-8-one from premnaspirodiene as starting material.

Claims (26)

1. A method for producing (−)-premnaspirodiene from a terpene substrate, comprising the steps of:

(a) providing a terpene substrate to a host cell transformed or transfected with a vector comprising a sequence of nucleic acid residues encoding a premnaspirodiene synthase gene;

(b) culturing the host cell by fermentation under conditions suitable to produce (−)-premnaspirodiene from the terpene substrate, wherein:

the fermentation system comprises an aqueous and a non-polar solvent phase;

the non-polar solvent phase is substantially immiscible with the aqueous phase; and

the premnaspirodiene is sequestered in the non-polar solvent phase during fermentation; and

(c) isolating the (−)-premnaspirodiene from the non-polar solvent phase.

2. The method of claim 1 , wherein the step of providing the terpene substrate is performed by synthesis of the terpene substrate by the host cell.

3. The method of claim 2 , wherein the terpene substrate is farnesyl diphosphate.

4. The method of claim 1 , wherein the host cell is a eukaryotic cell.

5. The method of claim 4 , wherein the host cell is a yeast cell.

6. The method of claim 5 , wherein the host cell is a Saccharomyces cerevisiae cell.

7. A method for producing (−)-premnaspirodiene from a terpene substrate, comprising the steps of:

(a) providing a terpene substrate to a host cell transformed or transfected with a vector comprising a sequence encoding a premnaspirodiene synthase gene;

(b) culturing the host cell under conditions suitable to produce (−)-premnaspirodiene from the terpene substrate, wherein the (−)-premnaspirodiene is sequestered as it is produced during the culturing step; and

(c) isolating the (−)-premnaspirodiene.

8. The method of claim 1 , wherein the (−)-premnaspirodiene is isolated from the non-polar solvent phase by distillation.

9. The method of claim 8 , wherein the non-polar solvent phase is a vegetable oil.

10. The method of claim 9 , wherein the vegetable oil is a soybean oil.

11. The method of claim 8 , wherein the non-polar solvent phase is a high-molecular weight aliphatic hydrocarbon selected from among a straight-chain or branched-chain isomer of dodecane, tridecane, tetradecane, pentadecane, and hexadecane, wherein the high-molecular weight aliphatic hydrocarbon optionally is substituted with one or more hydroxy or halogen substituents such that the substituted hydrocarbon is substantially immiscible with the aqueous phase.

12. The method of claim 1 , wherein the premnaspirodiene synthase gene is from Hyoscyamus muticus.

13. The method of claim 5 , wherein the yeast cell overproduces farnesyl diphosphate.

14. The method of claim 1 , wherein the host cell is a bacteria, cyanobacteria, filamentous fungi or algae.

15. The method of claim 1 , wherein the culturing of the host cell is performed by batch fermentation, fed-batch fermentation or continuous fermentation.

16. The method of claim 7 , wherein sequestration is effected by binding the (−)-premnaspirodiene to a hydrophobic resin, and the (−)-premnaspirodiene is isolated from the resin.

17. The method of claim 7 , wherein culturing is effected by fermentation.

Assignments (3)
CHANGE OF ADDRESS FOR ASSIGNEE Recorded Oct 17, 2016
From: EVOLVA, INC.
To: EVOLVA, INC.
Reel/Frame 040381/0312 →
MERGER AND CHANGE OF NAME Recorded Feb 18, 2016
From: ALLYLIX INC.; ALLYLIX INC.
To: EVOLVA, INC.
Reel/Frame 037769/0922 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2012
From: JULIEN, BRYAN N.; WALLACE, DAVID M.
To: ALLYLIX, INC.
Reel/Frame 027759/0767 →
Continuity (4)
Division 12579232 · Oct 14, 2009
Continuation In Part 12052464 · Mar 20, 2008
Provisional Application 60919284 · Mar 20, 2007
Related Publication 20120129235A1 · May 24, 2012